Evidence map›Paper›PMID 31965263›Full record

ArticleIntensive care medicine2020

Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.

Elie Azoulay, Philippe R Bauer, Eric Mariotte, Lene Russell, Paul Knoebl, Ignacio Martin-Loeches, Frédéric Pène, Kathryn Puxty, Pedro Povoa, Andreas Barratt-Due and 11 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura.Journal of the advanced practitioner in oncology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Elie AzoulayCentre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France. elie.azoulay@aphp.fr.ORCID http://orcid.org/0000-0002-8162-1508
Philippe R BauerDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
Eric MariotteCentre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France.
Lene RussellDepartment of Intensive Care, Copenhagen University Hospital, RigshospitaletCopenhagen Academy for Medical Simulation and Education, University of Copenhagen, and the Capital Region of Denmark, Copenhagen, Denmark.
Paul KnoeblDivision of Hematology and Hemostasis Department of Medicine 1, Medical University of Vienna, Vienna, Austria.
Ignacio Martin-LoechesDepartment of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, St James Street, Dublin 8, Ireland.
Frédéric PèneCentre National Maladie Rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, Cochin Hospital and Paris University, Paris, France.
Kathryn PuxtyDepartment of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK.
Pedro PovoaPolyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal.
Andreas Barratt-DueDepartment of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
Jose Garnacho-MonteroIntensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
Julia WendonKing's College Hospital, London, UK.
Laveena MunshiInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.
Dominique BenoitGhent University Hospital, Ghent, Belgium.
Michael von Bergwelt-BaildonIntensive Care in Hematologic and Oncologic Patients, Munich, Germany.
Marco MaggioriniMedical Intensive Care Unit, University Hospital of Zurich, Zurich, Switzerland.
Paul CoppoCentre National Maladie Rare des Microangiopathies Thrombotiques, Service d'Hématologie, Saint-Antoine Hospital and Paris University, Paris, France.
Spero CatalandDepartment of Medicine, Ohio State University, Columbus, OH, USA.
Agnès VeyradierCentre National Maladies Rares des Microangiopathies Thrombotiques, Service d'Hématologie, Lariboisière Hospital and Paris University, Paris, France.
Andry Van de LouwDivision of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.
Nine-i Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article unfortunately contained a mistake. The penultimate row of Table 4 shows INR > 1.5 which is incorrect. The correct figure is INR < 1.5. The authors apologize for the mistake. The correct table is given below.

Identifiers

PMID31965263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.